These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21096014)

  • 1. A multiclass multivariate group comparison test: Application to drug safety.
    Tohme M; Lengelle R; Freytag V
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():4711-4. PubMed ID: 21096014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.
    Moore RA; Derry S; McQuay HJ; Straube S; Aldington D; Wiffen P; Bell RF; Kalso E; Rowbotham MC;
    Pain; 2010 May; 149(2):173-176. PubMed ID: 19748185
    [No Abstract]   [Full Text] [Related]  

  • 4. Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process.
    Quan H; Ma Y; Zheng Y; Cho M; Lorenzato C; Hecquet C
    Pharm Stat; 2015; 14(3):161-71. PubMed ID: 25612310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.
    Huang P; Tilley BC; Woolson RF; Lipsitz S
    Biometrics; 2005 Jun; 61(2):532-9. PubMed ID: 16011701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for qualitative heterogeneity: An application to composite endpoints in survival analysis.
    Oulhaj A; El Ghouch A; Holman RR
    Stat Methods Med Res; 2019 Jan; 28(1):151-169. PubMed ID: 28670972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of clinical significance.
    Turner JA; Turk DC
    Pain; 2008 Jul; 137(3):467-468. PubMed ID: 18455313
    [No Abstract]   [Full Text] [Related]  

  • 9. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study.
    Biard L; Porcher R; Resche-Rigon M
    Stat Med; 2014 Jul; 33(17):3047-57. PubMed ID: 24676752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.
    Yang S
    Stat Med; 2019 Feb; 38(4):601-612. PubMed ID: 30209818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.
    Howard G; Waller JL; Voeks JH; Howard VJ; Jauch EC; Lees KR; Nichols FT; Rahlfs VW; Hess DC
    Stroke; 2012 Mar; 43(3):664-9. PubMed ID: 22343650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple analyses in clinical trials: sound science or data dredging?
    Lord SJ; Gebski VJ; Keech AC
    Med J Aust; 2004 Oct; 181(8):452-4. PubMed ID: 15487966
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.
    Noma H; Maruo K; Gosho M; Levine SZ; Goldberg Y; Leucht S; Furukawa TA
    BMC Med Res Methodol; 2019 Feb; 19(1):33. PubMed ID: 30764757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling.
    Wolfsegger MJ; Jaki T
    Biom J; 2009 Dec; 51(6):1017-29. PubMed ID: 19998360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses.
    Güttner A; Kübler J; Pigeot I
    Stat Med; 2007 Mar; 26(7):1518-31. PubMed ID: 16903003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cluster-adjusted rank-based test for a clinical trial concerning multiple endpoints with application to dietary intervention assessment.
    Zhang W; Liu A; Tang LL; Li Q
    Biometrics; 2019 Sep; 75(3):821-830. PubMed ID: 30690718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical guide for multivariate analysis of dichotomous outcomes.
    Lee J; Tan CS; Chia KS
    Ann Acad Med Singap; 2009 Aug; 38(8):714-9. PubMed ID: 19736577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods of correcting for multiple testing: operating characteristics.
    Brown BW; Russell K
    Stat Med; 1997 Nov; 16(22):2511-28. PubMed ID: 9403953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.